Real-time enrollment status for this waldenstrom macroglobulinemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT05734495 |
| Recruiting Status | Recruiting |
| Condition | Waldenstrom Macroglobulinemia |
| Phase | Clinical Trial |
| Target Enrollment | 42 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | May 11, 2025 (May 11, 2025) |
As of March 2, 2026: Clinical trial NCT05734495 is currently recruiting participants. This clinical trial study for waldenstrom macroglobulinemia is actively seeking new participants at 2 locations across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05734495 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05734495 was last updated May 11, 2025 (May 11, 2025). HelloStudys verifies this status automatically.